Fulviglen 250mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Fulvestrant (250mg)
Overview Fulviglen 250mg Injection
Estrogen suppression is achieved with the intramuscular Fulviglen 250mg Injection, indicated for postmenopausal women with breast cancer. Its mechanism involves estrogen modulation, thereby inhibiting cancer cell proliferation. Administered intramuscularly under medical supervision, dosage and frequency are determined by individual patient needs and prescribed treatment goals. Treatment duration aligns with the physician's recommendations. Commonly reported adverse effects include injection site reactions, headache, nausea, vomiting, and allergic responses. Any concerning or persistent side effects warrant immediate medical attention; management strategies may be available. Prior to initiating Fulviglen, disclose any history of hepatic or renal impairment, bleeding disorders, anticoagulant use, or concurrent medications to your physician. Further, inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Uses of Fulviglen 250mg Injection
Malignant breast tumor
Major Benefits of Fulviglen 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fulviglen 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulviglen 250mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Fulviglen 250mg Injection works:
Fulviglen 250mg Injection inhibits estrogen's effects on breast cancer cells, potentially halting or reducing the proliferation of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Fulviglen 250mg Injection concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Fulviglen 250mg Injection during pregnancy is contraindicated due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Fulviglen 250mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Administering a 250mg Fulviglen injection typically does not impair driving ability.
KidneyCAUTION
Exercise caution when administering Fulviglen 250mg Injection to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Fulviglen 250mg Injection use in such patients is limited. Dosage alteration is not advised for patients exhibiting mild or moderate kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Fulviglen 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulviglen 250mg Injection :
Omit a Fulviglen 250mg Injection dose? Seek your physician's advice.
Facts to Know About Fulviglen 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Estrogen Derivatives |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Estrogen receptor blocker |
3,018 People bought this recently